Vaneck Vectors Pharmaceutical etf shares owned by UBS Group
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.1M | 14k | 81.37 |
| 2023-09-30 | $872k | 11k | 79.86 |
| 2023-06-30 | $980k | 12k | 78.77 |
| 2023-03-31 | $1.1M | 14k | 77.63 |
| 2022-12-31 | $32M | 412k | 77.74 |
| 2022-09-30 | $34M | 510k | 67.28 |
| 2022-06-30 | $38M | 494k | 76.84 |
| 2022-03-31 | $1.0M | 13k | 79.83 |
| 2021-12-31 | $443k | 5.8k | 76.95 |
| 2021-09-30 | $548k | 7.5k | 72.75 |
| 2021-06-30 | $457k | 6.2k | 73.17 |
| 2021-03-31 | $718k | 10k | 69.03 |
| 2020-12-31 | $421k | 6.3k | 66.49 |
| 2020-09-30 | $430k | 6.9k | 62.11 |
| 2020-06-30 | $475k | 7.6k | 62.22 |
| 2020-03-31 | $611k | 11k | 54.43 |
| 2019-12-31 | $802k | 13k | 64.24 |
| 2019-09-30 | $573k | 10k | 56.97 |
| 2019-06-30 | $693k | 12k | 58.65 |
| 2019-03-31 | $726k | 12k | 60.79 |
| 2018-12-31 | $736k | 13k | 54.73 |
| 2018-09-30 | $1.1M | 18k | 64.62 |
| 2018-06-30 | $992k | 17k | 58.91 |
| 2018-03-31 | $956k | 17k | 56.81 |
| 2017-12-31 | $5.7M | 97k | 59.10 |
| 2017-09-30 | $7.0M | 121k | 57.76 |
| 2017-06-30 | $6.3M | 106k | 59.06 |
| 2017-03-31 | $5.5M | 100k | 55.14 |
| 2016-12-31 | $5.2M | 99k | 52.51 |
| 2016-09-30 | $1.1M | 20k | 57.48 |
| 2016-06-30 | $962k | 16k | 59.15 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf